<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346916</article-id>
      <article-id pub-id-type="pmc">3875966</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132328</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Epidermodysplasia Verruciformis in a young man with HIV since birth -
Case report<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Epidermodisplasia Verruciforme em um jovem com HIV desde o nascimento -
relato de caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Meireles</surname>
            <given-names>Sheila Itamara Ferreira do Couto</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Andrade</surname>
            <given-names>S&#xF4;nia Maria Fonseca</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Lima J&#xFA;nior</surname>
            <given-names>Cristiano Luiz Horta</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pires</surname>
            <given-names>Mario Cezar</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Medical doctor - Resident in the Dermatology Service of the Padre Bento
de Guarulhos Hospital Complex- Guarulhos (SP), Brazil.</aff>
      <aff id="aff02"><label>2</label> Dermatologist - Assistant physician in the Dermatology Service of the
Padre Bento de Guarulhos Hospital Complex- Guarulhos (SP), Brazil.</aff>
      <aff id="aff03"><label>3</label> Master in skin oncology from the Funda&#xE7;&#xE3;o Ant&#xF4;nio Prudente - Hospital
AC Camargo - Assistant physician in the Dermatology Service of the Padre Bento de
Guarulhos Hospital Complex- Guarulhos (SP), Brazil.</aff>
      <aff id="aff04"><label>4</label> Doctorate in dermatology, State Public Employees Hospital, and Director
of the Research Unit at the Padre Bento de Guarulhos Hospital Complex- Guarulhos (SP),
Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address: </bold>Sheila Itamara Ferreira do Couto Meireles, Av Em&#xED;lo
Ribas, 1819- Guarulhos, 07050-001 - S&#xE3;o Paulo - SP, Brazil. E-mail:
<email>sheilaifc@bol.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>190</fpage>
      <lpage>192</lpage>
      <history>
        <date date-type="received">
          <day>01</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Epidermodysplasia Verruciformis is a genodermatosis characterized by susceptibility
to infection by specific HPV types (HPV 3/10 and beta-HPVs). It is considered to be
the first model in human carcinogenesis induced by HPV. In this report we present a
rare case of Epidermodysplasia Verruciformis associated with vertical transmission of
HIV. Although most patients with HIV present infections by HPV virus, the frequency
of Epidermodysplasia Verruciformis is no greater in patients with HIV because in EV
there is a deficiency of specific cellular immunity to infection by some types of
HPV, called HPV-related Epidermodysplasia Verruciformis.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A Epidermodisplasia Verruciforme &#xE9; uma genodermatose que se caracteriza pela
susceptibilidade &#xE0; infec&#xE7;&#xE3;o por tipos espec&#xED;ficos de HPV (HPVs 3 e 10 e os beta-HPVs)
e &#xE9; considerada o primeiro modelo no homem de carcinog&#xEA;nese induzida pelo HPV. Neste
artigo apresenta-se um caso raro de Epidermodisplasia Verruciforme em um paciente com
HIV desde o nascimento. Apesar dos doentes com HIV apresentarem mais infec&#xE7;&#xF5;es pelos
v&#xED;rus HPVs, existem poucos relatos na literatura de Epidermodisplasia Verruciforme no
doente com HIV. Isso se explica, pois a Epidermodisplasia Verruciforme &#xE9; consequ&#xEA;ncia
de uma defici&#xEA;ncia celular espec&#xED;fica &#xE0; infec&#xE7;&#xE3;o por alguns tipos distintos de HPVs,
ditos HPVs relacionados a Epidermodisplasia Verruciforme.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>DNA probes, HPV</kwd>
        <kwd>Epidermodysplasia verruciformis</kwd>
        <kwd>HIV</kwd>
        <kwd>HIV infections</kwd>
        <kwd>Immunity, cellular</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Epidermodysplasia Verruciformis (EV) is a rare affection of recessive autosomal
transmission as described by Lutz and Lewandowski in 1922, although there are reports of
a possible recessive heritage connected to the X.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup> EV can be both familial and sporadic. Androphy et al consider the
sporadic form more common. <sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>EV is characterized by a susceptibility to chronic infections by different types of
Human Papiloma Virus (HPV).<sup><xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>The specific HPVs involved in the EV pathogenesis are 3 and/or 10 types (associated to
flat verruca), and the beta-HPVs 5, 8, 9, 12, 14, 15, 17, 19-25, 36-38, 47 and 50
types.</p>
      <p>The clinical picture begins in childhood and adolescence (5-11 years). It is expressed
by flat verruca-type lesions, maculae and isolated or confluent papule, erythematous
and/or hypochromic, and can present desquamation. The lesions generally begin on the
face and in the cervical region, with later generalization, but sparing the scalp and
mucosa. Itching and ardor appear occasionally, normally associated with sun
exposure.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>The clinical lesions can resemble a flat verruca, versicolor pityriasis, psoriasis and
seborrheic keratoses. <sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>EV diagnosis must be suspected when persistent verrucas are present in large body areas
and are thus difficult to treat.<sup><xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>EV patients possess specific cellular immunity against certain kinds of HPV.
Consequently, flat wart lesions are distributed generally, and on account of the
oncogenic action of the virus, actinic keratosis and carcinomas can develop, mainly in
photo-exposed areas. Lesions can become malignant in approximately 30% of cases, more
commonly in the third and fourth decades of life, and spinocellular carcinoma, the most
frequent type, can be aggressive and even present metastasis.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>Histologically, the lesions present stereotypical keratinocytes enlarged on the upper
epidermis with a grey-blue cytoplasm and pyknotic nucleus.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>The present case report refers to a patient with EV and vertical infection by HIV. </p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>22-year-old male reporting non-pruriginous lesions which appeared in the pre-adolescent
period, initially on the neck, with later dissemination. He denied relatives with a
similar condition and consanguinity between his parents. HIV was present since birth,
and the patient was under non-regular treatment with antiretroviral drugs. </p>
      <p>Dermatological examination showed isolated flat and some confluent, erythematous
papulae, discreetly desquamative on the neck, trunk, and limbs. (<xref ref-type="fig" rid="f01">Figures 1</xref>-<xref ref-type="fig" rid="f03">3</xref>) </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Isolated and confluent erythematous papulae forming verruca-type plaques on the
upper chest</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0190-g01"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Erythematous and hypochromic desquamative plaques on the back</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0190-g03"/>
      </fig>
      <p>Laboratory examinations showed positive anti-HIV, CD4: 84; Viral Load: 4.188. </p>
      <p>The histopathological examination revealed wide grayish-blue keratinocytes with pyknotic
nucleus on the upper third of the epiderm. These findings were compatible with EV.
(<xref ref-type="fig" rid="f04">Figures 4</xref> and <xref ref-type="fig" rid="f05">5</xref>) </p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Transition from the normal epidermis and the compromised area</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0190-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Stereotypical grayish-blue cytoplasm and keratinocytes with pyknotic nucleus on
the upper epiderm</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0190-g05"/>
      </fig>
      <p>The <italic>in situ </italic>hybridization was negative to the
6-1116-18-31-33-35-39-45-51-52-56-58-59-68 HPVs. These were not present in the EV, thus
allowing an accurate diagnosis to be made. </p>
      <p>Treatment with oral acitretine was proposed but the patient missed follow-up at our
dermatology clinic. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>EV is a genodermatosis characterized by susceptibility to the infection by specific
types of HPVs (3 and 10 HPVs and beta-HPVs). It is considered to be the first model of
carcinogenesis in men induced by HPV. </p>
      <p>The clinical picture of EV may present only flat verruca associated to non-oncogenic 3
and/or 10 HPVs, called the "benign form", or expressed in a polymorphic way tending to
malignancy associated with multiple HPVs, the major ones being: 5, 8, 14 and 47, called
the "malignant form". The initial presence of flat verrucas followed by the onset of a
polymorphism characteristic of the malignant form defines the "mixed form".<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>This patient was considered to carry EV in its benign form, since dissemination
consisted only of similar flat wart lesions. Moreover, the hystopathological examination
showed the cytopatic effect of the virus only on the upper part of the epidermis,
typical of the benign form, while the malignant form involves the entire epidermis
(<xref ref-type="fig" rid="f05">Figure 5</xref>). </p>
      <p>The condition is not specifically related to gender or race. Reports suggest that around
10% of EV carriers are the product of a consanguineous marriage. Our patient's parents
did not however report consanguinity. We considered the case as sporadic given that the
patient denied having relatives with a similar disease. </p>
      <p>Infection by the HPV virus in HIV carriers is common, but fewer than 20 cases of EV have
been reported in patients infected with HIV.<sup><xref ref-type="bibr" rid="r06">6</xref></sup> A possible explanation might be that EV poses immunological
changes of specific cellular immunity against different types of HPVs: beta-HPVs and the
3 and 10 HPVs. Such immunological deficiency would appear to be local and exclusive,
determining the inappropriate presentation of specific antigens to HPV defense
cells.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>There are even fewer such cases described in the EV literature on HIV vertically
infected patients, as in this particular case.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>No definitive treatment exists for EV, but photo-protection is recommended from
childhood onwards. </p>
      <p>Treatment of EV with oral retinoids has been described as producing a number of
benefical effects including their antiviral and antineoplasmatic actions. The use of
systemic or intra-injury Alpha-2a Interferon alfa-2a has also been described, with
immunomodulator, antiviral and antiproliferous actions. </p>
      <p>Silva <italic>et al </italic>have reported a case treated with oral 0.75 mg/kg/day
Acitretine and Alpha-2a Interferon 3.000.000 UI via SC, 3 times a week, with almost
complete regression of the lesions and few collateral effects.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at the Padre Bento de Guarulhos Hospital Complex- Guarulhos (SP),
Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>WRP</given-names>
            </name>
            <name>
              <surname>Neto</surname>
              <given-names>CF</given-names>
            </name>
            <name>
              <surname>Tyring</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Clinical aspects of epidermodysplasia verruciformis</article-title>
          <source>An Bras Dermatol</source>
          <year>2002</year>
          <volume>77</volume>
          <fpage>545</fpage>
          <lpage>556</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Pires</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Sittart</surname>
              <given-names>JAS</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia verruciformiscombined treatment with acitretin and
interferon alpha-2a</article-title>
          <source>An Bras Dermatol</source>
          <year>2006</year>
          <volume>81</volume>
          <fpage>595</fpage>
          <lpage>597</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;</surname>
              <given-names>NB</given-names>
            </name>
            <name>
              <surname>Guerini</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Barbato</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Di Giunta</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nunes</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia verruciformisclinical presentation with varied forms
of lesions</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S57</fpage>
          <lpage>S60</lpage>
          <pub-id pub-id-type="pmid">22068772</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Androphy</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Dvoretzky</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lowy</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>X-linked inheritance of epidermodisplasia
verruciformis</article-title>
          <source>Arch Dermatol</source>
          <year>1985</year>
          <volume>121</volume>
          <fpage>864</fpage>
          <lpage>868</lpage>
          <pub-id pub-id-type="pmid">2990354</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berk</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Bruckner</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Epidermodysplasia verruciform-like lesions in an HIV
patient</article-title>
          <source>Dermatol Online J</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>1</fpage>
          <lpage>1</lpage>
          <pub-id pub-id-type="pmid">19281706</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fitzpatrick</surname>
              <given-names>TB</given-names>
            </name>
          </person-group>
          <source xml:lang="pt">Tratado de dermatologia</source>
          <edition>7. ed</edition>
          <publisher-loc>Rio de Janeiro</publisher-loc>
          <publisher-name>Revinter</publisher-name>
          <year>2011</year>
          <comment>Cap&#xED;tulo 196, Infec&#xE7;&#xE3;o pelo papilomav&#xED;rus</comment>
          <fpage>1914</fpage>
          <lpage>1923</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lowe</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Katsidzira</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Meys</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sterling</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>de Koning</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Quint</surname>
              <given-names>W</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Acquired epidermodysplasia verruciformis due to multiple and unusual
HPV infection among vertically-infected, HIV-positive adolescents in
Zimbabwe</article-title>
          <source>Clin Infect Dis</source>
          <year>2012</year>
          <volume>54</volume>
          <fpage>e119</fpage>
          <lpage>e123</lpage>
          <pub-id pub-id-type="pmid">22474219</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f02" orientation="portrait" position="float">
      <label>FIGURE 2</label>
      <caption>
        <p>Erythematous and hypochromic verrucous papulae on the backs of the forearms</p>
      </caption>
      <graphic xlink:href="abd-88-06-s1-0190-g02"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
